(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;desacetylcefotaxime;Cefotaxime impurity;3-Desacetyl CefotaxiMe;Cefpirome Sodium Impurity 1;Cefotaxime Sodium EP Impurity B;Deacetylcefotaxime,Cefotaxime Impurity B (EP);Cefotaxime Impurity 2(Cefotaxime EP Impurity B);(7R)-7-[[[(2-Amino-4-thiazolyl)(methoxyimino)methyl]carbonyl]amino]-3-(hydroxymethyl)cepham-3-ene-4-carboxylic acid;(6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;(6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-(MethoxyiMino)acetyl]aMino]-3-(hydroxyMethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;desacetylcefotaxime
Cefotaxime EP Impurity B is a fully characterized chemical compound used as a reference standard of API Cefotaxime. The standard offered is compliant with regulatory guidelines. Cefotaxime EP Impurity B is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 66340-28-1
